A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆
Titel:
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆
Auteur:
Winquist, Eric Moore, Malcolm J. Chi, Kim N. Ernst, D. Scott Hirte, Hal North, Scott Powers, Jean Walsh, Wendy Boucher, Therese Patton, Robert Seymour, Lesley